Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-16

FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for a generic rivastigmine tartrate product from Dr. Reddy's Laboratories (ANDA). Rivastigmine tartrate is indicated for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine tartrate (rivastigmine tartrate)

Snippet

SUPPL AP for RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)